News
Important Only
BRIEF-3M Provides Medium-Term Financial Outlook At 2025 Investor Day
Feb 26 (Reuters) - 3M Co MMM.N:3M PROVIDES MEDIUM-TERM FINANCIAL OUTLOOK AT 2025 INVESTOR DAY; PRESENTS STRATEGIC PRIORITIES THAT WILL DRIVE GROWTH, OPERATIONAL EXCELLENCE, AND RETURN CASH TO SHAREHOLDERS3M CO - TO RETURN AT LEAST $10 BILLION IN CASH TO SHAREHOLDERS3M CO - REITERATES 2025 GUIDANCE, ...Reuters
Wed, Feb 26
BRIEF-United Parks & Resorts Inc QTRLY Revenue Was $384.4 Million
Feb 26 (Reuters) - United Parks & Resorts Inc PRKS.N:QTRLY REVENUE WAS $384.4 MILLIONQTRLY EPS $0.50Q4 EARNINGS PER SHARE VIEW $0.63, REVENUE VIEW $381.3 MILLION -- LSEG IBES DATASource text: ID:nPn5qfr51aFurther company coverage: PRKS.NReuters
Wed, Feb 26
BRIEF-Valens Semiconductor Q4 Revenue USD 16.665 Million
Feb 26 (Reuters) - Valens Semiconductor Ltd VLN.N:VALENS SEMICONDUCTOR Q4 REVENUE USD 16.665 MILLIONVALENS SEMICONDUCTOR Q4 ADJUSTED GROSS MARGIN 64.5%VALENS SEMICONDUCTOR Q4 OPERATING EXPENSES USD -18.483 MILLIONVALENS SEMICONDUCTOR Q4 ADJUSTED EBITDA USD -3.688 MILLIONVALENS SEMICONDUCTOR Q4 ADJUS...Reuters
Wed, Feb 26
BRIEF-Perfect Corp Anticipates A Year-Over-Year Total Revenue Growth Rate Of 13% To 14.5% For 2025, Compared To 2024
Feb 26 (Reuters) - Perfect Corp SZ9.F:PERFECT CORP: ANTICIPATES A YEAR-OVER-YEAR TOTAL REVENUE GROWTH RATE OF 13% TO 14.5% FOR 2025, COMPARED TO 2024PERFECT CORP QTRLY EPS $0.01Source text: ID:nBw9TbMC1aFurther company coverage: SZ9.FReuters
Wed, Feb 26
BRIEF-Madrigal Announces Two-Year Data From The Compensated Mash Cirrhosis Arm Of The Maestro-Nafld-1 Trial
Feb 26 (Reuters) - Madrigal Pharmaceuticals Inc MDGL.O:MADRIGAL ANNOUNCES NEW TWO-YEAR DATA FROM THE COMPENSATED MASH CIRRHOSIS ARM OF THE MAESTRO-NAFLD-1 TRIAL DEMONSTRATING POTENTIAL BENEFIT OF REZDIFFRA™ (RESMETIROM) IN PATIENTS WITH COMPENSATED MASH CIRRHOSISMADRIGAL PHARMACEUTICALS INC - REPORT...Reuters
Wed, Feb 26
BRIEF-Kestra Medical Technologies IPO Price Expected Between $14.00 And $16.00 Per Share
Feb 26 (Reuters) - Kestra Medical Technologies Inc KMTS.O:KESTRA MEDICAL TECHNOLOGIES LTD - IPO PRICE EXPECTED BETWEEN $14.00 AND $16.00 PER SHAREKESTRA MEDICAL TECHNOLOGIES LTD - SEES IPO OF UP TO 10 MILLION COMMON SHARESFurther company coverage: KMTS.OReuters
Wed, Feb 26
BRIEF-Revelation Biosciences Doses First Patient In Prime Phase 1B Clinical Study Of Gemini In CKD Patients
Feb 26 (Reuters) - Revelation Biosciences Inc REVB.O:REVELATION BIOSCIENCES DOSES FIRST PATIENT IN PRIME PHASE 1B CLINICAL STUDY OF GEMINI IN CKD PATIENTSREVELATION BIOSCIENCES INC - TOP-LINE DATA EXPECTED BY MID-YEARSource text: ID:nBw4fk9lgaFurther company coverage: REVB.OReuters
Wed, Feb 26
BRIEF-Dole Q4 Revenue USD 2,167 Million
Feb 26 (Reuters) - Dole PLC DOLE.N:DOLE Q4 REVENUE USD 2,167 MILLIONDOLE Q4 ADJUSTED EBITDA USD 74.6 MILLIONDOLE Q4 EPS CONTINUING OPERATIONS USD 0.23DOLE Q4 ADJUSTED EPS USD 0.16DOLE Q4 ADJUSTED NET INCOME USD 15.3 MILLIONDOLE PLC - FOR OWN OPERATIONS, WILL FACE KNOWN SHORT-TERM HEADWIND IN 2025 FO...Reuters
Wed, Feb 26
BRIEF-Escalade Q4 EPS USD 0.19
Feb 26 (Reuters) - Escalade Inc ESCA.O:ESCALADE Q4 EPS USD 0.19ESCALADE Q4 BASIC EPS USD 0.2ESCALADE Q4 SALES USD 63.942 MILLIONESCALADE Q4 OPERATING INCOME USD 4.513 MILLIONESCALADE Q4 NET INCOME USD 2.7 MILLIONESCALADE Q4 PRETAX PROFIT USD 4.267 MILLIONESCALADE INC SAYS BOARD AUTHORIZED CURRENT SH...Reuters
Wed, Feb 26
BRIEF-Lowe's Outlook FY EPS USD 12.15-12.4
Feb 26 (Reuters) - Lowe's Companies Inc LOW.N:LOWE'S OUTLOOK FY EPS USD 12.15-12.4LOWE'S Q4 EPS USD 1.99LOWE'S Q4 SALES USD 18,553 MILLION VERSUS. IBES ESTIMATE USD 18,292 MILLIONLOWE'S Q4 NET INCOME USD 1,125 MILLION VERSUS. IBES ESTIMATE USD 1,041 MILLIONLOWE'S Q4 OPERATING...Reuters
Wed, Feb 26
BRIEF-Avista Corp Initiated Consolidated Guidance Of $2.52 To $2.72 Per Share For 2025
Feb 26 (Reuters) - Avista Corp AVA.N:INITIATED CONSOLIDATED GUIDANCE OF $2.52 TO $2.72 PER SHARE FOR 2025EARNINGS PER DILUTED SHARE FOR Q4 2024 WAS $0.84: OVER THE LONG TERM, EXPECTS EARNINGS GROWTH IN THE 4-6 PERCENT RANGE FROM OUR FORECAST 2025 BASE YEARQ4 EARNINGS PER SHARE VIEW $0.86 -- LSEG IBE...Reuters
Wed, Feb 26
BRIEF-Taboolacom Ltd Reports Q4 2024 Revenues Of $491 Million
Feb 26 (Reuters) - Taboola.com Ltd TBLA.O:TABOOLACOM LTD - TABOOLA REPORTS Q4 2024 REVENUES OF $491 MILLIONTABOOLACOM LTD - TABOOLA REPORTS Q4 2024 EPS DILUTED OF $0.10TABOOLACOM LTD - TABOOLA ANNOUNCES $200 MILLION SHARE REPURCHASE EXPANSIONTABOOLA.COM OUTLOOK FY REVENUE $1,838 MILLION - $1,888 MI...Reuters
Wed, Feb 26
BRIEF-Taboola Reports Q4 & FY 2024 Financial Results
Feb 26 (Reuters) - Taboola.com Ltd TBLA.O:TABOOLA REPORTS STRONG FOURTH QUARTER & FULL YEAR 2024 FINANCIAL RESULTS; ANNOUNCES $200M SHARE REPURCHASE EXPANSION; LAUNCHES REALIZE PLATFORMSource text: ID:nGNX8W2g6DFurther company coverage: TBLA.OReuters
Wed, Feb 26
BRIEF-Siyata Mobile To Merge With Leading Ai Gaming Developer, Core Gaming
Feb 26 (Reuters) - Siyata Mobile Inc SYTA.O:SIYATA MOBILE SIGNS DEFINITIVE AGREEMENT TO MERGE WITH LEADING AI GAMING DEVELOPER, CORE GAMINGSIYATA MOBILE INC - TO ISSUE SHARES BASED ON $160 MILLION VALUATION OF CORE GAMINGSIYATA MOBILE : LEGACY SIYATA HOLDERS TO HAVE RIGHT TO RECEIVE DIVIDEND WITHIN ...Reuters
Wed, Feb 26
BRIEF-Arhaus Q4 Revenue USD 347 Million Versus. Ibes Estimate USD 351.3 Million
Feb 26 (Reuters) - Arhaus Inc ARHS.O:ARHAUS Q4 REVENUE USD 347 MILLION VERSUS. IBES ESTIMATE USD 351.3 MILLIONARHAUS Q4 ADJUSTED EBITDA USD 41 MILLION VERSUS. IBES ESTIMATE USD 38.3 MILLIONOUTLOOK FY NET REVENUE $1.36 BILLION TO $1.40 BILLIONOUTLOOK Q1 NET REVENUE $303 MILLION TO $323 MILLIONQ1 REVE...Reuters
Wed, Feb 26
BRIEF-DT Midstream Inc QTRLY Operating Earnings Per Share $0.94
Feb 26 (Reuters) - DT Midstream Inc DTM.N:DT MIDSTREAM INC - QTRLY OPERATING EARNINGS PER SHARE $0.94DT MIDSTREAM INC SAYS INCREASED 2025 ADJUSTED EBITDA GUIDANCE RANGE TO $1.095 TO $1.155 BILLION, 18% INCREASE OVER 2024 ORIGINAL GUIDANCEDT MIDSTREAM INC SAYS PROVIDED 2026 ADJUSTED EBITDA EARLY OUTL...Reuters
Wed, Feb 26
BRIEF-Lineage Inc 2025 Guidance Adjusted EBITDA $1.35-$1.40 Billion, AFFO Per Share $3.40-$3.60
Feb 26 (Reuters) - Lineage Inc LINE.O:LINEAGE INC - 2025 GUIDANCE: ADJUSTED EBITDA $1.35-$1.40 BILLION, AFFO PER SHARE $3.40-$3.60LINEAGE INC - Q4 AFFO PER SHARE $0.83Source text: ID:nBw4jVz9caFurther company coverage: LINE.OReuters
Wed, Feb 26
BRIEF-Global Net Lease Announces Sale Of Multi-Tenant Portfolio For Approximately $1.8 Billion
Feb 26 (Reuters) - Global Net Lease Inc GNL.N:GLOBAL NET LEASE ANNOUNCES SALE OF MULTI-TENANT PORTFOLIO FOR APPROXIMATELY $1.8 BILLIONGLOBAL NET LEASE INC - ANNOUNCES $300 MILLION SHARE REPURCHASE PROGRAMGLOBAL NET LEASE INC - EXPECTS $3 BILLION IN DISPOSITIONS BY END OF 2025GLOBAL NET LEASE INC - P...Reuters
Wed, Feb 26
